Allogeneic Mesenchymal Precursor Cells (MPC) in Diabetic Nephropathy: A Randomized, Placebo-controlled, Dose Escalation Study

2016178 citationsJournal Articlegold Open Access

Authors

Karen R. Segal · Mesoblast (United States)

Abstract

This study demonstrates the safety of rexlemestrocel-L in diabetic nephropathy with suggestive effects on renal function to be confirmed in larger, appropriately powered trials.

Topics & Keywords

Mesenchymal stem cell research Advanced Glycation End Products research Chronic Kidney Disease and Diabetes

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: EBioMedicine

Volume 12, pp. 263-269

DOI: 10.1016/j.ebiom.2016.09.011

Field-Weighted Citation Impact: 6.65